Reaction Details |
| Report a problem with these data |
Target | Kynurenine--oxoglutarate transaminase 1 |
---|
Ligand | BDBM50386292 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_826600 (CHEMBL2050768) |
---|
IC50 | 22000±n/a nM |
---|
Citation | Dounay, AB; Anderson, M; Bechle, BM; Campbell, BM; Claffey, MM; Evdokimov, A; Evrard, E; Fonseca, KR; Gan, X; Ghosh, S; Hayward, MM; Horner, W; Kim, JY; McAllister, LA; Pandit, J; Paradis, V; Parikh, VD; Reese, MR; Rong, S; Salafia, MA; Schuyten, K; Strick, CA; Tuttle, JB; Valentine, J; Wang, H; Zawadzke, LE; Verhoest, PR Discovery of Brain-Penetrant, Irreversible Kynurenine Aminotransferase II Inhibitors for Schizophrenia. ACS Med Chem Lett3:187-192 (2012) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Kynurenine--oxoglutarate transaminase 1 |
---|
Name: | Kynurenine--oxoglutarate transaminase 1 |
Synonyms: | CCBL1 | Cysteine-S-conjugate beta-lyase | Glutamine--phenylpyruvate transaminase | KAT1_HUMAN | KYAT1 | Kynurenine Aminotransferase 1/Glutamine Transaminase K | Kynurenine--oxoglutarate transaminase 1 |
Type: | Aminotransferase; Lyase |
Mol. Mass.: | 47874.00 |
Organism: | Homo sapiens (Human) |
Description: | Recombinant hKAT-1 was expressed and purified from Sf9 insect cells. |
Residue: | 422 |
Sequence: | MAKQLQARRLDGIDYNPWVEFVKLASEHDVVNLGQGFPDFPPPDFAVEAFQHAVSGDFML
NQYTKTFGYPPLTKILASFFGELLGQEIDPLRNVLVTVGGYGALFTAFQALVDEGDEVII
IEPFFDCYEPMTMMAGGRPVFVSLKPGPIQNGELGSSSNWQLDPMELAGKFTSRTKALVL
NTPNNPLGKVFSREELELVASLCQQHDVVCITDEVYQWMVYDGHQHISIASLPGMWERTL
TIGSAGKTFSATGWKVGWVLGPDHIMKHLRTVHQNSVFHCPTQSQAAVAESFEREQLLFR
QPSSYFVQFPQAMQRCRDHMIRSLQSVGLKPIIPQGSYFLITDISDFKRKMPDLPGAVDE
PYDRRFVKWMIKNKGLVAIPVSIFYSVPHQKHFDHYIRFCFVKDEATLQAMDEKLRKWKV
EL
|
|
|
BDBM50386292 |
---|
n/a |
---|
Name | BDBM50386292 |
Synonyms: | CHEMBL2047851 |
Type | Small organic molecule |
Emp. Form. | C9H10N2O2 |
Mol. Mass. | 178.1879 |
SMILES | N[C@H]1Cc2ccccc2N(O)C1=O |r| |
Structure |
|